جستجوی استاد راهنمای دانشگاهی

Patrick Bolanمشاهده پروفایل

دانشیار

• Medical Imaging
• Radiology
• Cancer Research
• +۳ مورد دیگر

Patrick Bolan, PhD is an Associate Professor in the Department of Radiology at the University of Minnesota. He serves as Associate Medical Director of the Center for Clinical Imaging Research and Associate Director of the Center for Radiology Research Resources. He is also faculty in the PhD Program in Medical Physics. His research focuses on advanced MRI and MRS techniques for cancer diagnosis and treatment monitoring, particularly in breast and prostate cancers. Key areas include developing AI-driven imaging protocols, quantitative MRI parameter estimation, and clinical translation of spectroscopic methods. Dr. Bolan leads interdisciplinary efforts in optimizing diffusion-weighted imaging (DWI), multiparametric MRI for treatment response prediction, and automated image analysis using deep learning. His work bridges clinical needs with cutting-edge imaging technologies, aiming to improve diagnostic accuracy and therapeutic decision-making. He has contributed to international standards for proton MRS in neuroimaging and breast cancer assessment through initiatives like the ISMRM and ACRIN trials. He holds leadership roles in radiology research infrastructure, overseeing imaging research resources and fostering collaboration between clinical and technical teams. His lab focuses on translational research, advancing imaging biomarkers for personalized oncology care.

Michael J. Evansمشاهده پروفایل

استاد

• Chemical Biology
• Positron Emission Tomography (PET)
• Targeted Radioligand Therapy
• +۷ مورد دیگر

Michael J. Evans, PhD, is a Professor in Residence at the University of California, San Francisco (UCSF), in the Department of Radiology and Biomedical Imaging. As a chemical biologist, his research focuses on biomarker discovery, nuclear medicine, and theranostics, particularly in oncology. He earned a BA in Chemistry from St. Mary’s College of Maryland and a PhD in Organic Chemistry from The Scripps Research Institute, followed by a postdoctoral fellowship in Molecular Imaging at Memorial Sloan Kettering Cancer Center. Dr. Evans leads a multidisciplinary lab at UCSF’s Genentech Hall, collaborating with radiochemists, engineers, and clinicians to develop imaging tools and therapies. His lab’s work includes preclinical and clinical studies of radioligands and targeted radiotherapies, such as CDCP1-targeted therapies and GRIP B-based immune monitoring. Notable achievements include the Roger Tsien Award (2023) and the Sam Gambhir Trailblazer Award (2024). His research has produced over 80 peer-reviewed articles and 13 patents. Current projects involve imaging immune responses via granzyme B and exploiting iron dysregulation in tumors. Dr. Evans mentors students and postdocs, including those in the Chemistry and Chemical Biology programs at UCSF. His lab actively pursues translational research, with clinical trials evaluating radiotracers like 18F-TRX and 64Cu-GRIP B. Dr. Evans has held leadership roles in professional societies, including the Society of Nuclear Medicine and Molecular Imaging, and serves on scientific advisory boards. His work bridges chemical biology and clinical nuclear medicine, aiming to improve cancer diagnosis and treatment.

Sina Houshmandمشاهده پروفایل

استادیار

• Molecular Imaging
• Nuclear Medicine
• Radiology
• +۴ مورد دیگر

Sina Houshmand, MD is an Assistant Professor of Radiology at the University of California, San Francisco (UCSF), within the School of Medicine. His academic career includes postdoctoral research at the University of Pennsylvania, residency training at the University of Pittsburgh Medical Center, and an abdominal imaging/ultrasound fellowship at UCSF. He specializes in molecular imaging, particularly using PET techniques for oncology, cardiovascular diseases, and pediatric disorders. Education and Training: Earned his MD from Shahid Beheshti University of Medical Sciences (Tehran, Iran), followed by an internship in Internal Medicine at Albert Einstein College of Medicine/Montefiore Medical Center. Completed diagnostic radiology residency at UPMC and abdominal imaging fellowship at UCSF. Research: Focuses on novel applications of PET imaging, including 18F-NaF and 18F-FDG as molecular probes for atherosclerosis and calcium metabolism biomarkers. Recent work explores AI-driven diagnostic tools and multimodal imaging approaches for cancer and neurological disorders. Awards: Received the Radiology Resident Distinguished Achievement Award (2021) for scholarly contributions and innovation. His research spans over 60 peer-reviewed publications, emphasizing PET quantification, AI in radiology, and clinical imaging applications. Labs/Teams: Active in UCSF's abdominal imaging and molecular imaging research groups, collaborating on projects involving AI integration and advanced contrast agents.

Lisa Arendtمشاهده پروفایل

دانشیار

• Obesity
• Breast Cancer
• Mammary Gland Biology
• +۵ مورد دیگر

Lisa Arendt is an Associate Professor in the Department of Comparative Biosciences at the University of Wisconsin-Madison, School of Veterinary Medicine. Her research focuses on understanding how obesity influences breast cancer development and progression, particularly in postmenopausal women. She investigates the role of inflammation, adipose tissue changes, and tumor microenvironment dynamics in promoting aggressive tumor behaviors. Education: B.S. in Genetics, University of Wisconsin-Madison (1996) D.V.M., School of Veterinary Medicine, University of Wisconsin-Madison (2002) Ph.D. in Cellular and Molecular Biology, University of Wisconsin-Madison (2007) Postdoctoral Fellowship in Cancer Biology, Tufts University (2014) Research Interests: Obesity's impact on breast cancer risk, mammary gland biology, tumor microenvironment interactions, inflammation-driven carcinogenesis, and stromal-epithelial cross-talk. Her lab employs mouse models, xenograft systems, and 3D cell culture to study mechanisms linking obesity to aggressive tumor phenotypes, metastasis, and therapeutic resistance. Labs/Teams: The Arendt Lab at UW-Madison explores how adipose tissue changes under obesity drive tumor formation and progression. Key areas include: Obesity-induced inflammation and fibrosis in mammary tissue Role of macrophages and stromal cells in tumor angiogenesis Hormonal interactions (e.g., estrogen, aromatase) in postmenopausal breast cancer

Katherine Brumbergمشاهده پروفایل

استادیار

• Statistics
• Biostatistics
• Epidemiology
• +۳ مورد دیگر

Katherine Brumberg is an Assistant Professor of Statistics at the University of Michigan's Department of Statistics, part of the College of Literature, Science, and the Arts (LSA). Her office is located in 445C West Hall. Her research focuses on statistical methodologies in observational studies, including covariate balancing, stratification techniques, and applications in biostatistics and epidemiology. She has published extensively on topics such as optimal strata refinement, unmeasured bias analysis, and differential gene expression studies. Her recent work (2023-2024) emphasizes advancements in observational study design, leveraging statistical optimization and linear programming to address covariate imbalances. Earlier research includes studies on prostate tissue gene expression (2018). No scientific awards are explicitly listed in the provided materials. She contributes to the academic community through courses like Introductory Statistics for Data Analysis and maintains an active research profile within the Department of Statistics.

• Health Psychology
• Medical Decision-Making
• Patient Education
• +۴ مورد دیگر

Professor Ilona Juraskova holds a tenured position as Professor of Health Psychology at the School of Psychology, University of Sydney, with roles spanning education (40%), research (40%), and leadership (20%). She serves as Deputy Director of the Centre for Medical Psychology and Evidence-based Decision-making (CeMPED) and Director of the healthCARE research group. Her research focuses on medical decision-making, patient education, psychosexual health in oncology, and genomic ethics. She leads initiatives like the eTRIO communication training modules and Navigate prostate cancer decision aid. Educational Background: Ph.D. in Health Psychology (documented in her 2009 book on psycho-sexual adjustment post-gynaecological cancer). Current projects include CoGenT (dynamic consent platforms) and TRIO-Conflict modules for oncology nurses. She has secured grants such as the 2023 'Improving the consent process for genomic testing for CALD patients' and 2022 'Adaptation of dynamic consent platforms'. Her work bridges clinical practice and research, with 133+ publications. Key contributions include decision aids for cancer patients, caregiver engagement programs, and genomic sequencing ethics frameworks. She collaborates with organizations like Cancer Council NSW and the Charles Perkins Centre.

Mohammad Asimمشاهده پروفایل

مدرس ارشد

• Cancer Biology
• Prostate Cancer
• Androgen Receptor Signaling
• +۳ مورد دیگر

Dr. Mohammad Asim is a Senior Lecturer (Associate Professor) at the University of Surrey, leading the Androgen Signalling Lab within the School of Biosciences. He specializes in prostate cancer research, focusing on molecular mechanisms driving cancer progression and novel therapeutic development. His academic journey includes a PhD from Justus Liebig University, postdoctoral training at the University of Wisconsin, and a senior scientist role at the CRUK Institute, Cambridge. Education: BSc (First Class) in Science, Rohilkhand University MSc in Science, Hamdard University, New Delhi PhD in Cancer Biology, Justus Liebig University, Germany Research Interests: Dr. Asim's work centers on androgen receptor signaling pathways, transcriptional regulation, and drug resistance in prostate cancer. His lab explores translational approaches to identify therapeutic targets and develop novel inhibitors. Key projects include investigating neuroendocrine transdifferentiation drivers and exploiting choline kinase alpha as a chaperone for AR. Publications: Over 30 peer-reviewed articles focus on prostate cancer mechanisms, with recent work highlighting hybrid androgen receptor inhibitors and AR variant 7 target genes. Research spans molecular biology, pharmacology, and clinical translation. Awards: Recognized as a Fellow of the Royal Society of Biology (2019) and recipient of the SHOUT Teaching Excellence Award (2018). Active in professional societies including AACR and AAAS. Teaching: Leads molecular biology modules (BMS2036, BMS1047) and contributes to advanced gene expression technologies (BMS3092). Committed to student-centered education and mentorship. Labs/Teams: Heads the Androgen Signalling Lab, collaborating on interdisciplinary projects with clinical and computational teams to advance prostate cancer therapies.

S. Duke Herrellمشاهده پروفایل

استاد

• Surgical Robotics
• Urologic Surgery
• Image Guidance Systems
• +۳ مورد دیگر

S. Duke Herrell is a tenured Professor of Urology, Biomedical Engineering, and Mechanical Engineering at Vanderbilt University's School of Engineering. His interdisciplinary work focuses on advancing surgical robotics, image guidance systems, and medical device innovation for minimally invasive procedures. Education: M.D. from the University of Virginia and B.A. from the University of Richmond. Research emphasizes robotic systems for urologic surgeries, including transurethral interventions and concentric tube robots. His work bridges engineering and medicine, with contributions to MRI-guided prostate resection, bladder perforation repair, and CO2 pyelography alternatives. Key innovations include touch-based image guidance frameworks and VR prototyping for surgical robots. Publications highlight advancements in robotic accuracy, safety protocols, and surgical tool design. Though no formal awards are listed, his contributions to urologic robotics are widely recognized in academic circles.

Ling Huangمشاهده پروفایل

دانشگاهی

• Cancer Research
• Pharmacology
• Toxicology
• +۵ مورد دیگر

Ling Huang is a Research Assistant Professor affiliated with Henry Ford Health System and Michigan State University's Department of Pharmacology and Toxicology. Her research focuses on pancreatic cancer, organoid modeling, drug screening, and cancer immunotherapy. She holds a PhD in Biological Sciences from Purdue University and a B.S. in Biochemistry from East China University of Science and Technology. Huang's work has been supported by grants from the Hirshberg Foundation and National Foundation for Cancer Research. Education: PhD, Biological Sciences, Purdue University (2003–2009) B.S., Biochemistry, East China University of Science and Technology (1999–2003) Research Interests: Her studies explore therapeutic strategies for pancreatic cancer using patient-derived organoids, including EZH2 targeting and personalized tumor vaccines. She investigates circulating tumor cells (CTCs) to predict treatment responses and develops novel drug targets through genomic and single-cell analyses. Her work bridges basic cell biology, pharmacology, and translational oncology. Grants and Funding: Investigating EZH2 targeting in pancreatic cancer using organoids (Hirshberg Foundation) CTC-based predictive models for chemotherapy responses (National Foundation for Cancer Research) Labs and Affiliations: Huang collaborates with teams at Henry Ford Hospital and MSU's Life Science Building, leveraging organoid platforms and cutting-edge genomic tools to advance pancreatic cancer research.

Jack Cuzickمشاهده پروفایل

استاد

• Cancer Epidemiology
• Clinical Trials
• Cancer Prevention
• +۷ مورد دیگر

Jack Cuzick is the John Snow Professor of Epidemiology at Queen Mary University of London, heading the Cancer Prevention unit within the Wolfson Institute of Population Health. He previously directed the Wolfson Institute of Preventive Medicine and the Centre for Cancer Prevention. With a PhD in Mathematics, he has held roles at Oxford University and Columbia University. His research focuses on cancer epidemiology, clinical trials, and prevention/screening strategies, particularly breast, cervical, and prostate cancers. He is a leading authority on HPV-based cervical screening, chemoprevention, and biomarker development. Key achievements include pioneering work on tamoxifen’s role in breast cancer prevention, developing molecular markers for cancer prognosis, and leading major trials like IBIS and ATAC. Cuzick has authored over 500 peer-reviewed papers in top journals and earned prestigious awards, including the CBE and CRUK Lifetime Achievement Prize. Education: PhD in Mathematics Research Interests: Chemoprevention of breast cancer HPV-based cervical screening Colorectal cancer screening via flexible sigmoidoscopy Prostate cancer biomarkers and risk assessment Statistical methodologies for clinical trials Personalized risk-based cancer screening strategies Recent Research Trends: Focus on polygenic risk scores, epigenetic biomarkers (e.g., DNA methylation), and computational pathology tools for predicting treatment response. Recent studies explore aspirin’s role in cancer prevention and the impact of hormonal factors on anastrozole efficacy. Awards: Fellowships: Royal Society, Academy of Medical Sciences, Royal Statistical Society 2017 CBE (services to cancer prevention) CRUK Lifetime Achievement Prize (2017) AACR Cancer Prevention Prize (2012) Grants/Advising: Leads major initiatives like the IBIS-II Prevention Trial and the ATAC Trial. Collaborates on global projects such as the International Breast Cancer Intervention Study (IBIS) and the ARTISTIC cohort for cervical cancer biomarkers. No formal student advisee list is provided in the text. Labs/Teams: Directs the Cancer Prevention unit and collaborates with the Centre for Prevention, Detection and Diagnosis at Queen Mary. Engages with international networks like the Trans-Atlantic Prostate Group.

Hiro Farabiمشاهده پروفایل

پژوهشگر

• Health Economics
• Public Health
• Healthcare Policy
• +۸ مورد دیگر

Dr. Hiro Farabi is a Health Economist at Queen Mary University of London (QMUL), affiliated with the Wolfson Institute of Population Health and the Pragmatic Clinical Trials Unit (PCTU) at the Centre for Evaluation and Methods (CEM). He holds a BSc from the University of Isfahan (2007), an MSc in Economics from Urmiya University (2010), and a PhD in Health Economics from Iran University of Medical Sciences (2021). His research focuses on health economics methodologies including cost-benefit analysis, cost-effectiveness analysis, activity-based costing, and systematic reviews of economic evaluations. Key interests include decision-analytic modeling, revealed and stated preferences in healthcare, and outcome assessment frameworks. His work spans diverse areas such as cancer screening economics, palliative care cost analyses, telemedicine utilization, and vaccine demand in low- and middle-income countries. He has published extensively on healthcare cost drivers in Iranian hospitals and contributed to studies on genetic testing, osteoporosis burden, and medical education costs. His affiliations with PCTU and CEM reflect his involvement in methodological and translational research in population health. Recent publications highlight themes of optimizing healthcare resource allocation, evaluating telemedicine impacts, and modeling patient willingness-to-pay for preventive care. His systematic reviews synthesize evidence on cost-effectiveness of treatments like osimertinib and palliative care interventions.

Michael R. Kingمشاهده پروفایل

استاد

• Mechanobiology
• Immunoengineering
• Cancer Metastasis
• +۵ مورد دیگر

Michael R. King is the E.D. Butcher Chair of Bioengineering and CPRIT Scholar at Rice University, serving as Special Advisor to the Provost for Life Science Collaborations with the Texas Medical Center. His research focuses on mechanobiology, immunoengineering, and cancer metastasis, with emphasis on cellular responses to fluid shear stress and nanomedicine applications. King holds a PhD in Chemical Engineering from the University of Notre Dame and completed postdoctoral training at the University of Pennsylvania. He leads the King Lab, which develops 3D in vitro models of metastasis and investigates mechanotransduction in immune and cancer cells. Key projects include engineering fluid shear stress-activated immune therapies and superhydrophobic surfaces for cancer aggregate cultures. His work is funded by NIH and CPRIT, and he mentors postdocs and graduate students in biomedical engineering. King serves as Editor-in-Chief of Cellular and Molecular Bioengineering and has held leadership roles in AIMBE, BMES, and other professional societies. His honors include fellowships in AAAS, NAI, and multiple teaching awards. The King Lab also actively seeks donations to advance cancer research efforts.

TERRY GAASTERLANDمشاهده پروفایل

استاد

• Genomics
• Metagenomics
• Bioinformatics
• +۵ مورد دیگر

Terry Gaasterland is a Professor of Marine Biology at the Scripps Institution of Oceanography, UC San Diego, and Director of the Scripps Genome Center. His research focuses on genomics, metagenomics, and bioinformatics, with applications to microbial genetics, cancer biology, and stem cell differentiation. He holds a B.S. in Computer Science and Russian from Duke University, and a M.S. and Ph.D. in Computer Science from the University of Maryland, College Park. Education: B.S., Computer Science and Russian, Duke University M.S., Computer Science, University of Maryland, College Park Ph.D., Computer Science, University of Maryland, College Park (Thesis: 'Generating Cooperative Answers in Deductive Databases') Research Interests: Microbial genome annotation and comparative genomics Alternative splicing in eukaryotic genes and its role in cancer and development Regulation of RNA through microRNAs and RNA-binding proteins Therapeutic targeting of cancer stem cells in metastatic prostate cancer Stem cell differentiation mechanisms using Wnt signaling pathways Integration of genomics and bioinformatics in marine biology Research Trends: His work spans computational biology, cancer therapy development, and marine microbial ecology, with recent emphasis on applying AI to biological databases and understanding mechanisms of castration-resistant prostate cancer. Labs/Teams: Directs the Scripps Genome Center, leading interdisciplinary projects in genomics and bioinformatics. Collaborates with clinical teams on CAR-T cell therapy and cancer stem cell research.

Katja Strohfeldtمشاهده پروفایل

استاد

• Pharmaceutical Chemistry
• Metal-Based Anti-Cancer Drugs
• Quality Assurance of Herbal Medicines
• +۳ مورد دیگر

Professor Katja Strohfeldt is a Professor of Pharmaceutical Chemistry and Associate Pro-Vice-Chancellor (Education and Student Experience) at the University of Reading. She leads strategic initiatives in teaching and learning across multiple schools, including Agriculture, Archaeology, Built Environment, and Mathematical Sciences. Her academic career includes roles as School Director of Teaching and Learning and Warden of Stenton Hall. Strohfeldt earned a PhD in Chemistry from the University of Wuerzburg, Germany, followed by postdoctoral research in Dublin on metal-based anti-cancer drugs. She joined the University of Reading in 2006 and was promoted to Professor in 2018. Her research focuses on anticancer drug design (particularly titanocene and ruthenium complexes), quality assurance of herbal medicines, and innovative teaching methods like problem-based learning (PBL). Her textbook Essentials of Inorganic Chemistry integrates PBL case studies for pharmacy education. Awards include University Teaching Fellow and Principal Fellow of the Higher Education Academy. She sits on the British Pharmacopoeia’s Expert Advisory Group and contributes to regional academic governance. Key achievements include advancing data-driven improvements in teaching quality, developing PBL frameworks for large classes, and publishing over 40 peer-reviewed articles. Her research group explores thrombosis modulation via metal complexes and herbal medicine standardization.

Paul Andrew Johnstonمشاهده پروفایل

استاد

• Drug Discovery
• Cancer Research
• High Content Imaging
• +۵ مورد دیگر

Paul Andrew Johnston is a Professor of Pharmaceutical Sciences at the University of Pittsburgh School of Pharmacy. He holds a B.Sc. (Honors) and Ph.D. in Biochemistry from the University of East Anglia, followed by postdoctoral research at UNC Chapel Hill, Duke University, and the Howard Hughes Medical Institute. With over 30 years of drug discovery experience across academia and industry, his expertise spans high content imaging, HTS/HCS assay development, and 3D tumor modeling. He founded the University of Pittsburgh Molecular Library Screening Center (PMLSC), leading 21 HTS campaigns and pioneering the ALMANAC database for cancer drug combinations. His current research focuses on prostate cancer, melanoma, head/neck cancer, and hepatocellular carcinoma drug discovery through innovative screening approaches. Education: B.Sc. with Honors (2.1), Biochemistry, University of East Anglia (1978) Ph.D., Biochemistry, University of East Anglia (1983) Research Focus: Integrating advanced imaging technologies with high-throughput screening to identify synergistic drug combinations and novel therapeutics. Specializes in patient-derived 3D tumor models, androgen receptor inhibition in prostate cancer, and overcoming drug resistance mechanisms. Active in developing standardized HTS protocols for precision medicine applications. Key Contributions: Developed NCI-60 cell line combination screening methodologies, pioneered multicellular tumor spheroid analysis frameworks, and established organoid models for personalized cancer therapy evaluation. Served as past president of the Society for Biomolecular Imaging and Informatics (SBI2). Advising & Grants: Mentors Pharm.D. and Ph.D. students in drug discovery. Leads collaborative projects with academic and industry partners, including work on HDAC8 inhibitors for kidney injury and Src kinase modulators. Actively participates in grant initiatives related to cancer drug discovery and assay development. Labs & Facilities: Director of chemical biology laboratories within the School of Pharmacy's Pharmaceutical Sciences department. Oversees the PMLSC's HTS/HCS facilities and maintains close ties with the University of Pittsburgh Liver Research Center for collaborative oncology studies.